Aptabio.com

Aptabio.com has server used 121.78.88.93 (Korea) ping response time Hosted in KINX Register Domain Names at Whois Corp.. This domain has been created 11 years, 314 days ago, remaining 6 years, 50 days. You can check the 6 Websites and blacklist ip address on this server

Domain information

Registrar WHOIS Server: whois.whois.co.kr

Registrar URL: http://www.whois.co.kr     See All 0+

Creation Date: 2009-07-01 11 years, 314 days

Updated Date: 2020-07-01 313 days ago

Expiry Date: 2027-07-01 6 years, 50 days left     See All

  Sign up for notifications near expiration

Registrar: Whois Corp.

Abuse Email: [email protected]

Abuse Phone: +82.15884259

  Full details

Top 10 Hosting Providers

Registrar URLDomain CountsRegistrar NameAbuse Email
www.godaddy.com2,280,668GoDaddy.com, LLC[email protected]
www.tucows.com535,579Tucows Domains Inc.
networksolutions.com526,027Network Solutions, LLC[email protected]
www.namecheap.com333,839NameCheap, Inc.[email protected]
www.enom.com299,925eNom, LLC
www.publicdomainregistry.com294,948PDR Ltd. d/b/a PublicDomainRegistry.com[email protected]
www.whois.godaddy.com174,077GoDaddy.com, LLC[email protected]
www.fastdomain.com161,753FastDomain Inc.[email protected]
www.ionos.com159,2071&1 IONOS SE[email protected]
www.networksolutions.com149,653Network Solutions, LLC[email protected]

Full view & Download

Keywords Suggestions

  › Aptabio therapeutics

  › Apta bio

  › Apta biofeedback

  › Apta biosciences

  › Aptaboc

  › Aptabody

  › Aptability

  › Ap tibiofemoral mobilization

  › Aptability in executive functioning

  › Aptabeacon

  › Aptation

  › Aptations.com

  › Aptations 60012

  › Aptations 32001hw

  › Aptations 91243hw

  › Aptations meaning

  › Aptations mirror

  › Aptations lighting

  › Aptations linkedin

  › Aptations wall mirror

  › Aptations makeup mirror

See More:   A   B   C   D   E   F   G   H   I   J   K   L   M   N   O   P   Q   R   S   T   U   V   W   X   Y   Z  

› Aptabio therapeutics inc

› Aptabio therapeutics

Hosting Provider

NetName: KINXINC

Organization: KINX     See All 13,010+

Provider URL: Nic.or.kr

Hostname: servera93.opencom.com

IP Server: 121.78.88.93 Reg: , Updated: 2017-02-02T01:43:53Z

Blacklist: Check Backlist Status

Country: Korea

Address: Jeollanam-do Naju-si Jinheung-gil, KR

Latitude: 37.511200

Longitude: 126.974098

Name Server:

  • NS1.GAMGAKDESIGN.COM
  • NS2.GAMGAKDESIGN.COM

Abuse Email: [email protected]

Abuse Phone: +82-2-580-4600

Top 10 Hosting Providers

Website URLDomain CountsOrganizationAbuse Email
Google.com681,421Google LLC[email protected]
Godaddy.com650,706GoDaddy.com, LLC[email protected]
Cloudflare.com637,900Cloudflare, Inc.[email protected]
Endurance.com488,827The Endurance International Group, Inc.[email protected]
Amazon.com439,891Amazon Technologies Inc.[email protected]
297,405Domain Name Services
Amazonaws.com287,121Amazon Technologies Inc.[email protected]
Liquidweb.com159,971Liquid Web, L.L.C[email protected]
Squarespace.com150,667Squarespace, Inc.[email protected]
Ripe.net128,362RIPE Network Coordination Centre[email protected]

Full view & Download

List of found email addresses

No Emails Found

Find Websites hosted

1: Aptabio.com

2: Clubinner.com Changed to: 114.111.53.87

3: Kobia.kr Changed to: 211.43.203.64

4: Guju.co.kr

5: Anyfeel.xyz

6: Timepieceasia.com

At least 6 Sites on this server

Port Scanner (IP: 121.78.88.93)

AptaBio Corporate Headquarters, Office Locations And

  • AptaBio is headquartered in Yongin-si, Korea (Republic of) and has 1 office location across 1 country

Craft.co   DA: 8 PA: 18 MOZ Rank: 26

Aptoide Download, Find And Share The Best Apps And Games

Aptoide Official Homepage - Download the best games and apps on Aptoide! Find, download and share APKs for Android on our community driven platform

En.aptoide.com   DA: 14 PA: 14 MOZ Rank: 29

Safety, Tolerability And Renal Effects Of APX-115 In

  • ClinicalTrials.gov Identifier: NCT04534439 Other Study ID Numbers: A01-115-02-EU 2019-004155-37 ( EudraCT Number ) First Posted: September 1, 2020 Key Record Dates: Last Update Posted: March 25, 2021 Last Verified: March 2021 Individual Participant Data (IPD) Sharing Statement:

Clinicaltrials.gov   DA: 18 PA: 21 MOZ Rank: 41

AptaBio Therapeutics (KOSDAQ:A293780)

How has AptaBio Therapeutics's share price performed over time and what events caused price changes? Latest Share Price and Events Stable Share Price : A293780 is more volatile than 75% of KR stocks over the past 3 months, typically moving +/- 12% a week.

Simplywall.st   DA: 13 PA: 50 MOZ Rank: 66

Aptabio To Initiate Phase II Oral Covid-19 Therapy Trial

  • Aptabio intends to conclude a confirmatory clinical trial based upon positive results from the Phase II trial and will submit an application seeking emergency use authorization
  • In a separate development, the Korea Disease Control and Prevention Agency (KDCA) has confirmed that GC Pharma’s plasma therapy is effective against the UK and South

Pharmaceutical-technology.com   DA: 33 PA: 36 MOZ Rank: 73

AptaBio Therapeutics, Inc., South Korea Institution

  • Sustainability, climate-change mitigation, and biomedical science are key areas for future research prowess in the Asia-Pacific region
  • While COVID-19 travel restrictions have disrupted collaborations between far-flung nations, they have

Natureindex.com   DA: 19 PA: 50 MOZ Rank: 74

Safety, Tolerability, PK And PD Of SAD Or MAD Of APX-115

  • ClinicalTrials.gov Identifier: NCT03694041 Other Study ID Numbers: OP101817.APT 2017-004252-30 ( EudraCT Number ) First Posted: October 3, 2018 Key Record Dates: Last Update Posted: March 11, 2019 Last Verified: March 2019 Individual Participant Data (IPD) Sharing Statement:

Clinicaltrials.gov   DA: 18 PA: 21 MOZ Rank: 45

Korean Pharmaceutical Company AptaBio Has Been Proved

On 16th, AptaBio Co., Ltd., a South Korean biopharmaceutical company specialized in developing treatments of anti-cancer and diabetic complications, announced that it had demonstrated the effectiveness of COVID-19 treatment candidates.The company stated that through cell experiments, its NADPH oxidase (NOX) enzyme inhibitor treatment agent, APX-115, has been proved effective in t..

Us.acrofan.com   DA: 14 PA: 11 MOZ Rank: 32

Hope Biosciences Licenses Nuc-Gemcitabine, A 'Trojan Horse

AptaBio's NOX inhibitors include the 'first-in-class' candidate, APX-115 against diabetic nephropathy, APX-1004 against diabetic retinopathy, and APX …

Prnewswire.com   DA: 18 PA: 50 MOZ Rank: 76

Aptabio Therapeutics Inc., #0504, A, Tower-dong, 13

  • Location - Aptabio Therapeutics Inc
  • Executives - Aptabio Therapeutics Inc
  • CEO - Chief Executive Officer (CEO - Chief Executive Officer) Other Companies recomended by Kompass: Buy your prospection list

Us.kompass.com   DA: 14 PA: 37 MOZ Rank: 60

AptaBio (293780.KQ) Stock / Share Price, Revenue And

  • AptaBio market cap is ₩580 b.
  • View AptaBio stock / share price, financial statements, key ratios and more at Craft.

Craft.co   DA: 8 PA: 16 MOZ Rank: 34

Top AptaBio Competitors And Alternatives Craft.co

  • AptaBio is a biopharmaceutical company focused on the discovery and development of selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs
  • Jiangsu Hansoh Pharmaceutical Group
  • Jiangsu Hansoh Pharmaceutical Group is …

Craft.co   DA: 8 PA: 20 MOZ Rank: 39

Aptabio Therapeutics VentureRadar

  • focuses on research and development of diabetic complications and intractable cancer drugs
  • We are developing drugs for major indications based on the NOX inhibitor discovery platform and Apta-DC platform technology
  • VentureRadar Research / Company Website.

Ventureradar.com   DA: 20 PA: 50 MOZ Rank: 82

AptaBio Therapeutics Inc. BIO-Europe

  • BIO-Europe is Europe's largest partnering conference serving the global biotechnology industry
  • The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies
  • Produced with the support of BIO, it is regarded as a “must attend” event for the biotech industry.

Informaconnect.com   DA: 18 PA: 45 MOZ Rank: 76

293780 AptaBio Therapeutics Inc. Stock Price & News

  • View the latest AptaBio Therapeutics Inc
  • (293780) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Wsj.com   DA: 11 PA: 29 MOZ Rank: 54

Aptabio (293780.KQ) Stock Price, News, Quote & History

Find the latest Aptabio (293780.KQ) stock quote, history, news and other vital information to help you with your stock trading and investing.

Finance.yahoo.com   DA: 17 PA: 17 MOZ Rank: 49

Hope Biosciences Release: Company Licenses Nuc-Gemcitabine

  • 23, 2017 /PRNewswire/ -- HOPE BIOSCIENCES announced today that it has acquired the exclusive rights to develop and commercialize nuc-gemcitabine (APTA-12/HOPE-888) through a licensing agreement with AptaBio Therapeutics, a Korean pharmaceutical company
  • nuc-Gemcitabine consists of Antisoma's AS1411*, a clinically-tested DNA aptamer against surface …

Biospace.com   DA: 16 PA: 50 MOZ Rank: 82

Find Emails And Phone Numbers Of Professionals In South

Emails and Direct Phone Numbers of professionals in South Korea Search and Find Anyone's Email Address, Direct Phone Number and Much More ZoomInfo’s database provides access to over 209 million professional profiles and 13 million business profiles, including more direct dials and email addresses of professionals in South Korea than any other market intelligence provider.

Zoominfo.com   DA: 16 PA: 35 MOZ Rank: 68

Analyst Coverage LogicBio Therapeutics, Inc.

  • is followed by the analysts listed above
  • Please note that any opinions, estimates or forecasts regarding LogicBio Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of LogicBio Therapeutics, …

Investor.logicbio.com   DA: 21 PA: 39 MOZ Rank: 78

AptaBio Therapeutics (KOSDAQ:293780) Is In A Strong

  • AptaBio Therapeutics has a market capitalisation of ₩295b and burnt through ₩8.8b last year, which is 3.0% of the company's market value
  • So it could almost certainly just borrow a little to fund another year's growth, or else easily raise the cash by issuing a few shares.

Simplywall.st   DA: 13 PA: 50 MOZ Rank: 82

Recently Analyzed

1: Bluesky-wireless.com 1 seconds ago

2: Shopinnewark.com 8 seconds ago

3: Ufa158.com 3 seconds ago

4: Broadwayfederalbank.com 2 seconds ago

5: Aptabio.com 2 seconds ago

6: Drmem.com 1 seconds ago

7: Chsknights.com 1 seconds ago

8: Vay-tien.com 1 seconds ago

9: Todaisushi.ca 2 seconds ago

10: Emurgo.io 2 seconds ago

Tool Checker

Domain Expiry Date Updated

Expiry DateExpiry DateDomain ProviderHosting Provider
Emurgo.io1 year, 13 days leftNameCheap, IncCloudflare, Inc.
Todaisushi.ca 144 days leftGo Daddy Domains Canada, IncAmazon Technologies Inc.
Vay-tien.com 241 days leftP.A. Viet Nam Company LimitedSuper Online Data Co.,Ltd
Chsknights.com 99 days left1&1 IONOS SE1&1 IONOS Inc.
Drmem.com4 years, 291 days leftGoDaddy.com, LLCDomain Name Services
Aptabio.com6 years, 50 days leftWhois Corp.purplestones
Broadwayfederalbank.com2 years, 339 days leftNetwork Solutions, LLCAT&T Services, Inc.
Ufa158.com 245 days leftName.com, Inc.Cloudflare, Inc.
Shopinnewark.com 220 days leftGoDaddy.com, LLCNASN Licensing Inc.
Bluesky-wireless.com 277 days left1&1 IONOS SEDomain Name Services

<< See All >>

.COM - 10,595,200+   .ORG - 1,117,549+   .EDU - 123,500+   .NET - 792,945+   .GOV - 30,232+   .US - 84,439+   .CA - 122,904+   .DE - 220,061+   .UK - 272,390+   .IT - 108,882+   .AU - 152,812+   .CO - 51,739+   .BIZ - 59,081+   .IO - 32,494+   .NL - 99,647+   .SG - 19,713+   .INFO - 81,589+   .IE - 26,934+   .ME - 25,076+   .FR - 98,576+   .EU - 61,372+   .RU - 165,043+   .PH - 9,511+   .INT - 1,166+   .IN - 87,021+   .ES - 38,035+   .CZ - 71,869+   .VN - 48,920+   .TV - 14,250+   .SITE - 9,829+   .RO - 37,484+   .PL - 44,520+   .PK - 10,373+   .MOBI - 4,464+   .LK - 5,507+   .CN - 66,137+   .CH - 66,914+   .AT - 31,992+  

Email Address Search | IP Address Blacklist Check | Hosting Providers | Domain Providers | Website Error Checker

© 2018 Site-Stats.org. All rights reserved. Email: [email protected]